"Executive Summary Intracranial Hematoma Drug Market : CAGR Value The global Intracranial Hematoma Drug Market was valued at USD 2.10 billion in 2024 and is expected to reach USD 4.10 billion by 2032. During the forecast period of 2025 to 2032, the market is projected to grow at a CAGR of 6.6%, primarily driven by the rising incidence of traumatic brain...